Morgan Stanley’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49 | Hold |
8
| – | – | ﹤0.01% | 7794 |
|
|
2025
Q1 | $45 | Hold |
8
| – | – | ﹤0.01% | 7759 |
|
|
2024
Q4 | $40 | Hold |
8
| – | – | ﹤0.01% | 7703 |
|
|
2024
Q3 | $54 | Buy |
8
+4
| +100% | +$27 | ﹤0.01% | 7557 |
|
|
2024
Q2 | $38 | Sell |
4
-6
| -60% | -$57 | ﹤0.01% | 7595 |
|
|
2024
Q1 | $135 | Sell |
10
-15
| -60% | -$203 | ﹤0.01% | 7346 |
|
|
2023
Q4 | $340 | Buy |
25
+12
| +92% | +$163 | ﹤0.01% | 7312 |
|
|
2023
Q3 | $300 | Hold |
13
| – | – | ﹤0.01% | 7358 |
|
|
2023
Q2 | $394 | Sell |
13
-1
| -7% | -$30 | ﹤0.01% | 7400 |
|
|
2023
Q1 | $322 | Buy |
14
+1
| +8% | +$23 | ﹤0.01% | 7481 |
|
|
2022
Q4 | $245 | Buy |
13
+4
| +44% | +$75 | ﹤0.01% | 7626 |
|
|
2022
Q3 | $0 | Sell |
9
-1
| -10% | – | ﹤0.01% | 7907 |
|
|
2022
Q2 | $0 | Sell |
10
-73
| -88% | – | ﹤0.01% | 8010 |
|
|
2022
Q1 | $3K | Sell |
83
-3
| -3% | -$108 | ﹤0.01% | 7696 |
|
|
2021
Q4 | $3K | Sell |
86
-4
| -4% | -$140 | ﹤0.01% | 7751 |
|
|
2021
Q3 | $3K | Hold |
90
| – | – | ﹤0.01% | 7612 |
|
|
2021
Q2 | $5K | Sell |
90
-1
| -1% | -$56 | ﹤0.01% | 7400 |
|
|
2021
Q1 | $5K | Sell |
91
-14
| -13% | -$769 | ﹤0.01% | 7118 |
|
|
2020
Q4 | $5K | Sell |
105
-93
| -47% | -$4.43K | ﹤0.01% | 6777 |
|
|
2020
Q3 | $6K | Sell |
198
-138
| -41% | -$4.18K | ﹤0.01% | 6422 |
|
|
2020
Q2 | $12K | Buy |
336
+181
| +117% | +$6.46K | ﹤0.01% | 6128 |
|
|
2020
Q1 | $6K | Sell |
155
-771
| -83% | -$29.8K | ﹤0.01% | 6162 |
|
|
2019
Q4 | $59K | Buy |
926
+540
| +140% | +$34.4K | ﹤0.01% | 5809 |
|
|
2019
Q3 | $27K | Buy |
386
+239
| +163% | +$16.7K | ﹤0.01% | 5930 |
|
|
2019
Q2 | $19K | Sell |
147
-41
| -22% | -$5.3K | ﹤0.01% | 5956 |
|
|
2019
Q1 | $27K | Sell |
188
-342
| -65% | -$49.1K | ﹤0.01% | 5921 |
|
|
2018
Q4 | $56K | Buy |
+530
| New | +$56K | ﹤0.01% | 5732 |
|